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Mergers and acquisitions within the chemical industry is a common practice to 
increase market presence and customer base.  Common justifications for M&A include 
synergy, business growth and competitive advantages, and management reasoning.  
Synergies are benefits a combined firm is able to receive through cost reductions, market 
expansion, and efficiencies in processes.  As a result, firms are able to grow and position
themselves competitively.  To prevent an overpriced acquisition, numerous valuation 
techniques exist.  The discount cash flow examines the value of a firm based on future 
cash flow.  The market multiple compares target firms to similar firms in the industry.  
Lastly, the asset valuation determines the value of a firm based on the liquidation of the 
firm.
To maximize the return on an acquisition, proper due diligence should be 
conducted based on the needs and goals of the purchaser, and the value added by the 
v
target firm.  The premium paid for an acquisition should be based on the valued added 
through the synergies identified.  Current business cycles and future outlook should also 
factor into the pricing of the acquisition.  Having a thorough analysis of a target firm can 
help the acquirer to clearly understand what is being purchased and hence, determine an 
appropriate price for the acquisition.
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Overpriced Mergers and Acquisitions in the Chemical Industry
In a globally competitive market, corporations are finding it difficult to create 
value through new products and services.  Competition has created an environment which 
demands shorter production time and reduced cost.  As a result, corporations are 
struggling to maintain a level of competitive advantage through their capabilities and 
expertise.  In an attempt to maintain the necessary competitive advantage, firms are 
looking towards mergers and acquisitions (M&A) as the mean for growth and value.  
Through such measures, firms are able to reinforce existing capabilities and access new 
skills.
The purchase price of a target firm should be based on the value added through 
the merger.  The value realized in an M&A depends in large part on how well the newly 
combined company identifies, manages, and executes on value creation and value capture 
opportunities (PricewaterhouseCoopers 2008).  However, it has been stated that as many 
as 70% of M&A’s fail to capture the added value and hence, produce the value 
shareholders expect (Greenberg et al 2008).  Different valuation techniques are available 
to help determine an appropriate price for an acquisition however, there are numerous 
reasons why firms often overpay for an acquisition including irrational exuberance about 
the strategic importance of the deal, and enthusiasm built up during the excitement of 
negotiations (Eccles, Lanes, and Wilson 1999).  Understanding the justifications for 
firms’ decision to engage in an M&A and the different valuation techniques available can 
inform and prevent firms from an overpriced acquisition.
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This research will attempt to determine some of the reasons for undertaking an 
acquisition and the valuation processes available to determine an appropriate purchase 
price.  The remainder of the paper will begin by examining the justifications for an 
(overpriced) M&A and studying the common valuation techniques used in M&A.  An 
analysis will be presented for investors and managers within the chemical industry on 
factors beneficial for a successful M&A. Information regarding the research methodology 
will then be presented, and concluded by a review of the main points, recommendations 
for firms considering an M&A, and recommendations for further research. 
JUSTIFICATIONS FOR MERGERS AND ACQUISITIONS
According to Amin et al. (2001), rapid changes in technology, competitive 
environment, corporate strategies, and other pressures prompt many firms to seek 
cooperative relationships with other companies.  Past mergers have shown that high level 
of optimism exists concerning the magnitude and timing of capturing synergies and 
operational savings.  Incorrect assumption can pose liquidity issues and reduce the net 
present value of the acquisition (Roman 2009).  Justifications for M&A should closely 
align with the company’s business and should be based on the risks and future goals of 
the combined firm.  Common reasons for engaging in M&A include synergy, business 
growth and competitive advantages, and management decision-making.  Understanding 
these reasons can shine light on the biases of these reasons. 
3
Synergy
Synergy is defined as two agents working together such that the value as a whole 
is greater than the sum of its parts.  It is generally used to describe the benefits a merged 
company receives which it could not otherwise achieve independently.  Synergy is often 
the primary motive for M&A as it leads to increased competitiveness and cash flows 
(Mukherjee, Kiymaz, and Baker 2004).  Executives often use synergy to justify a deal 
and for the excessive premium paid however, they set themselves up for problems as they 
attempt to define, capture, and track synergies in the deal (Ficery, Herd, and Pursche
2007).  Figure 1 provides a graphical representation of the various values a firm holds.
Figure 1: Different values for a given firm
The intrinsic value of a firm is the net present value of expected future cash flow.  
This value is independent of any acquisitions and is under the assumption the firm 
continues to operate as normal.  The market value of a firm reflects the added premium 
likely offered by a potential acquirer to the target company.  For a publicly traded 
company, this value is also the share price.  The synergy value is the net present value of 
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future cash flows resulting from improvements and added benefits from two firms 
coming together (Eccles, Lanes, and Wilson 1999).  In other words, the synergy value 
paid is the premium over the market value for the synergy created between the firms.
The premium paid for the acquisition of a company should be based on the 
expected synergies.  As a result, management should carefully determine and value all 
possible synergies arising from the merged company.  Synergies such as eliminating 
duplicate work, consolidating activities, and reducing headcount are easily identified and 
captured.  However, management frequently fails to realize the less easily defined 
synergies.  These include revenue synergies resulting from improvement in processes and 
joint efforts (Ficery, Herd, and Pursche 2007).  Consider a company trying to access a 
new geographic market and a new customer base.  The time and costs associated with 
such an implementation can be substantially reduced through M&A.  The value of this 
synergy would be the time and costs involved to enter a new geographic market 
independently.  Other intangible synergies include outcomes from knowledge sharing, 
joint research and development, and boarder and deeper scope of the company (Amin, 
Hagen, and Sterrett 1995).  These synergies are harder to monetize as they become 
drivers for additional value to the company.
Capturing synergies does present some challenges including the window 
opportunity to capture synergies and incorrect processes.  The window opportunities to 
capture synergies tend to be time sensitive, and research shows that successful acquirers 
capture 70-75% of the synergies during the first year after the close of the deal (Ficery, 
Herd, and Pursche 2007).  The focus on capturing synergies is lost over time, which leads 
executives to wait until another acquisition to capture the remaining synergies.  As time 
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destroys the value of synergies, executives continue to focus their attention on capturing 
the easiest, least significant synergies first.  As a result, capturing the true value adding 
synergies is delayed and the overall integration timeline is extended (Kissel, McCoy, and 
Charles 2009).  Best practice states that synergies should be prioritized based on the size, 
time, and difficulty in capturing the synergy.  Afterwards, work must be done to capture 
the biggest and easiest synergy in the least amount of time.  In the merger between two 
specialty chemical companies, this process allowed synergies to be captured 20% sooner 
and capture $85 million in synergies over and above the estimated $200 million target 
(Ficery, Herd, and Pursche 2007).
Incorrect processes can lead to unattained synergies.  It is not enough to just find 
synergies, but a process must be available to monitor the success of capturing the 
synergies.  Leading organizations use a strategic due diligence to identify, valuate, and 
prioritize synergies to handoff to integration teams.  The integration teams then focus on 
achieving the synergies utilizing tracking mechanisms linking synergies to financial plans 
and timetable (Ficery, Herd, and Pursche 2007).  Attempting to capture synergies through 
economies of scale and operational efficiencies from sharing best practices can prove 
difficult for corporate cultures which lack processes tied to a financial metric system.  In 
such instance, companies must leverage existing measurements systems, i.e. budgetary 
and financial goals, to monitor the synergies captured.
Synergies are the often the primary justifications for M&A.  Careful attention 
should be given to determine all possible synergies to justifiably pay the necessary 
premium to close the deal.  Synergies should be identified, valued, and captured based on 
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size, time, and difficulty in reaching the synergies.  It is then that a merged company can 
maximize its strengths and capabilities. 
Business Growth and Competitive Advantages
Business growth and competitive advantages are another common reason to 
pursue M&A.  The combined firm allows its business portfolio to expand its main line of 
business while achieving a lower cost of capital (through lower level of risks) and higher 
operating cash flows (Katz, Simanek, and Townsend 1997).  The business and 
competitive advantages can be realized through different means including revenue and 
market growth, cost reduction, and capital optimization.
In a competitive environment, internal or organic growth is often difficult to 
achieve.  M&A allows the purchaser to receive additional revenue and market growth by 
entering new markets and expanding into new geographies.  In addition, firms have 
access to new distribution channels and customer base, and have an opportunity to gain a 
stronger foothold in an industry which it may not have been able to do internally (Hunt, 
2003).  Combining firms from different industries allows the combined firm to enter into 
new markets with greater growth potential.  Merging within similar industries allows 
firms to gain economies of scale and scope.
Economies of scale refer to the competitive advantages resulting from operational 
efficiencies.  This theory states that a joined company can reduce its fixed costs by 
removing duplicate activities and headcounts and lowering the overall cost from R&D 
through production while providing a constant, if not increasing, revenue stream.  Joint 
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R&D and production effort, and marketing allow firms to benefit from the economies of 
scale (Amin, Hagen, and Sterrett 1995).  Less evident synergies include cross-selling of 
products in newly assessable market segments (Pursche, 1989).  Economies of scope 
refer to the competitive advantages from the transfer of skills and knowledge at a lower 
cost than if pursued independently.  This advantage provides companies access to new 
technology, greater brand awareness and reputation (Katz, Simanek, and Townsend
1997).
Merged firms also benefit from the reduced operational cost and improved 
operational efficiency.  The obvious cost reductions are from the removal of duplicate 
headcount and activities.  Cost savings also occur from economies of scale and 
purchasing power through volume discount.  M&A provides the opportunity to achieve 
operational efficiency as competitive advantages are achieved through the transfer of 
skills to critical activities.  One of the main reasons for M&A’s during the 1990s was the 
notion of knowledge-based competition allowing for faster and cheaper advancements 
through knowledge transfer (Katz, Simanek, and Townsend 1997).
Lesser recognized business growth and competitive advantage relates to capital 
optimization.  Firms are better able to utilize resources to maximize profits by combining 
uses of resources and closing duplicate or expensive facilities.  This in-turn will provide 
additional cost savings to the company.  M&A also provides firms a fitting occasion to 
streamline the human capital for improved operational efficiencies.  However, care must 
be taken to ensure there is no misalignment between the business and the workflow 
strategy – ultimately resulting in diminishing value in the M&A deal. 
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Management Decision-Making
Management is constantly seeking out new opportunities to increase revenue and 
to grow the company.  In doing so, senior managers should rigorously examine the 
emotional state of those supporting the deal and the reasoning provided to support the 
deal.  Studying a potential deal requires extensive time and effort that can create an 
emotional attachment.   Many deals often happen because managers fall in love with the 
idea of the deal (Eccles, Lanes, and Wilson 1999).  An emotional attachment can result 
from over commitment to the deal or when a manager personally is responsible for the 
acquisition decision.   
Over confidence also comes into play with managers of competitive nature.  
These individuals are certain in their judgment which leads them to value the target firm 
too positively – expecting significant synergies and benefits from the merger.  Industry 
trends and market performance will also influence management to consider M&A as a 
necessity (Reilly 2007).  Managers often over-credit their role in previous successful 
deals which leads to subsequent value destroying deals (Billett and Qian 2008).  To 
overcome these biases, management should seek out disconfirming evidence from 
objective experts and independent analysts, and from references of comparable prior 
deals.  This will help justify the validity of the deal.  The competitive nature also makes it 
difficult for managers to lose, especially during a bidding war with a rival competitor 
over a target firm (Eccles, Lanes, and Wilson 1999).    As a result, the purchase price is 
unjustifiably increased as managers are un-willing to be outbid.  In the end, managers 
will possess the winner’s curse as their ego will have led them to pay an unreasonable 
premium for the target company.  However, management will justify the higher-than-
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expected premium as a “strategic investment.”  This is the excuse used to justify an 
overpaid acquisition when the numbers do not add up (Eccles, Lanes, and Wilson 1999).
Another common argument to pursue a target firm is to prevent a competitor from 
acquiring it.  The fact remains that the purchase of a firm should be based on the value 
added in relation to the cost of the acquisition (Eccles, Lanes, and Wilson 1999).  
Therefore, if the calculated benefits are outweighed against the cost of the purchase, the 
purchaser should avoid placing itself in a weak competitive position by purchasing a less-
than favorable target firm.
The decision to merge or acquirer another firm should be based on reasonably 
estimated benefits and value added to the buyer.  The decision should consider all 
attainable synergies and benefits as well as the financial and business costs associated 
with the acquisition.  
VALUATION TECHNIQUES
Pricing an acquisition correctly is critically important provided the numerous 
M&A’s which take place and the high failure rate to capture the expected value from 
synergies and competitive advantages.  Moreover, many assume that companies have an 
absolute value but the strategic value of purchasing another firm is inherently relative 
given factors as market position of the buyer and competitiveness of the products it is 
acquiring (Seymour 1993).  
Value is often characterized as being dynamic, changing based on the context it is 
used in.  The basic value of a company is its intrinsic value.  This is the value based on 
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the net present value of future cash flow independent of any changes.  This is under the 
assumption that the company continues to operate under current management and 
processes (Eccles, Lanes, and Wilson 1999).  On top of the intrinsic value is the premium 
added to reflect the likelihood of an acquisition (Bertoncel 2006).  This is the market 
value.  Lastly, the synergy value refers to the target firm’s value as a combination of all 
benefits arising through the M&A.
Valuation analysts often disagree on what quantitative value constitutes fair 
market value.  However, it should be mentioned that paying more than “fair market 
value” does not equate to overpaying (Reilly, 2007).  Purchase price should be relative to 
similar M&A’s in the industry as well as the value added to the combined firms.  Each 
potential buyer will estimate the value of the acquisition given the post-merger financial 
projections and the buyer’s required rate of return.  Benchmarks to determine the 
purchase price of the target firm are 1) pay a price up to the amount where the target 
acquisition internal rate of return (IRR) equals or exceeds the buyer’s cost of capital and, 
2) a price up to the amount where the target acquisition net present value (NPV) equals or 
exceeds zero (Reilly 2007, and Bertoncel 2006).
 Numerous valuation techniques have developed to estimate a target’s value.  
There are three primary approaches to valuing a company: income approach, market 
approach, and asset approach.  Within these approaches various methods have evolved 
with unique characteristics.  All three approaches should be used in business valuation 
but, doing so may not be practical in certain situation.  Each approach may present 
constraints but it is important to recognize that each approach brings a unique perspective 
on value and its driver.  The income approach looks at future return discounted to reflect 
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the associated risks.  The market approach determines the value based on alternative 
investments, and the asset approach approximates the business valuation during 
liquidation (Evans and Bishop 2001).  Three commonly used valuation techniques used 
are the discount cash flow (DCF), market multiple, and asset valuation.  Using these 
techniques together will allow decision-makers to make an informed purchase offer.
Discount Cash Flow
Over time researchers have found increasing use of the DCF models in various 
corporate decision making environments and as a dominant investment-evaluation 
vehicle.  Greater importance is placed on this model as compared to the alternatives 
including market multiple and asset valuation (Mukherjee, Kiymaz, and Baker 2004).  
According to surveys conducted, firms primarily use the DCF model to determine the 
value of the target take-over.  
In M&A’s, the discount cash flow valuation technique attempts to determine the 
net present value of future cash flow over the life of a company.  Since companies are 
assumed to have infinite life, the DCF valuation is captured from the cash flows during 
the initial forecast period and the terminal period (Bertoncel 2006).  For the initial 
forecast period, cash flow estimates are projected which incorporate the benefits and 
costs associated with the transactions.   The initial forecast period generally refers to the 
first three to ten years after the M&A.  The terminal period of the company refers to the 
period beyond the initial period, and the terminal value, or residual value, refers to the 
value of future cash flow during the terminal period (Chaplinsky and Doherty 2000, and 
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Pratt, Reilly, and Schweihs 2000).    Once the cash flows have been approximated, the 
Weighted Average Cost of Capital (discount rate) is used to discount them to present 
value.  This is the business enterprise value. 
Cash flows are represented as the cash the companies has after all cash expenses 
have been taken out; it is the operating cash flow before the consideration of finance 
charges.  Cash flow equals after-tax earnings, plus depreciation and other non-cash 
charges, less net investments and changes in working capital.  Cash flow can be 
determined by taking the net profits and adding back depreciation and non-cash charges, 
and subtracting capital expenditure and changes in working capital (current liabilities
minus current assets) (McClure 2009).  Once the cash flow is determined for the initial 
period, they are discounted to the present value.  
Present Value =   , where:
 CF is the expected cash flow for the period ahead.
 WACC is the weighted average cost of capital
Terminal values are calculated in the final year of the initial forecast period, and 
discounted to the present value.  Various methods exist to calculate the terminal value.  
The liquidation value assumes that a firm will cease to exist at the end of the initial 
period.  This approach simply determines the value of the firm’s total assets adjusted for 
inflation.  The stable perpetual growth model assumes that a firm will grow at a constant 
rate, and the multiple growth valuation applies a multiple to a firm’s revenue.  For this 
research, focus will be placed on the stable perpetual growth model.  The following 
formula calculates the terminal value:
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Terminal Value =  , where:
 CF is the expected cash flow at the end of the initial forecast 
period.
 WACC is the weighted average cost of capital
 g is the expected constant growth rate in the perpetual period.
It is important to note that the present value of the terminal value often times 
accounts for a large portion of the firm’s value.  As a result, small changes in the growth 
rate will greatly change the terminal value.  As the growth rate gets closer to the discount 
rate (WACC), mathematically, the capitalization rate is zero or negative.  This leads to an 
unreasonable conclusion that the company is infinitely valuable (Pratt, Reilly, and 
Schweihs 2000).
Discount rate is an “opportunity cost” or the expected rate of return an investor 
would have to give up in investing in similar business given the risks; it is the rate of 
return which the market requires to attract investments.  In an M&A, the discount rate 
should reflect the entire capital structure of the target firm (Pratt, Reilly, and Schweihs
2000).  Businesses are usually financed through debt and equity with corresponding costs 
given the risk factors.  Therefore, the discount rate must reflect the combined weighted 
average cost of all capital sources.  
WACC = Wdkd (1 - T) + Weke , where:
 Wd and We are the percentage of debt and equity, respectively.
 T is the marginal tax rate.
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 kd and ke are the cost of debt and equity, respectively.
The cost of debt is frequently the yield to maturity given similar credit rating and 
maturity.  The cost of equity can be determined using the Capital Asset Pricing Model 
(CAPM).
ke = Rf  + β (Rm – Rf) , where:
 Rf   is the risk-free rate on a given security (usually defined as the 
ten year government treasury).
 Rm – Rf is the risk premium for similar investments.
 β (beta) is measure of a firm’s systemic risk. 
Once the cash flows during the initial forecast period and the terminal/residual 
values are determined, these values will need to be adjusted to the present value with the 
appropriate WACC.  The summation of these values will provide the intrinsic value of a 
company. 
Market Multiple
Market multiples is a widely used source to determine the value of a firm during 
an M&A.  It is based on the notion that one will not pay more than the price of equally 
available alternatives.  Thus, market multiples are based on similar companies within the 
industry.  The challenge therefore is to identify similar companies to provide a basis for 
comparison.   Depending on the characteristic and nature of the firm, it may be difficult 
to find comparable companies.  As a result, the search criteria will need to be broadened 
to find suitable companies for comparisons.  Frequent search criteria are based on size (as 
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defined by sales volume), specialty of products and services, markets and geographic 
presence, and financial performance (Evans and Bishop 2001).  Various multiples are 
available to apply against the target company.  Attention should be given to the market 
value of invested capital (MVIC) as defined by the price of equity and total debt 
(enterprise value).  Market multiples use various return measures including revenue, 
EBIT (earnings before interest and taxes), EBITDA (earnings before interest, taxes, 
depreciation, and amortization), and operating cash flow; typically multiples are based on 
the last twelve months of earnings.  Ratios of enterprise value to the different measure of 
returns are computed for the comparable companies.  These ratios should be arranged to 
provide a spectrum of small to large ratios to provide a valuation range for the target 
firm.  These ratios can then be applied against the revenue, EBIT, EBITDA, operating 
cash flow, or any other measure of the target firm.  This will provide valuation ranges 
based on the different measures used.
Consider the present pending M&A deal by CF Industries Holdings to acquire 
Terra Industries.  The market multiple for Terra Industries can be determined by 
examining the returns of a similar company within the industry such as Scotts Miracle-
Gro Company.  In November 2009, Scotts Miracle-Gro had an enterprise value of 
$3,658,686,000 and an EBITDA of $347,400,000 (SmartMoney 2009).  Thus, the market 
multiple for Scotts Miracle-Gro was 10.53 (enterprise value/EBITDA).  Applying this 
market multiple against the EBITDA ($500,481,000) for Terra Industries provides a 
market valuation of $5.27 billion.  This is near the vicinity of the latest $4.1 billion offer 
by CF Industries for Terra Industries.
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While using the market multiples, it is important to analyze the weight given to 
these multiples, and which measure to use in determining the market value.  Limited data 
may lead to placing little significance on the multiple, or using other measures of return.  
Similarly, data comparability may subject an analyst to adjust multiples to compensate 
for the differences between target firm and similar companies (Pratt, Reilly, and 
Schweihs 2000).  Data which are closely clustered or widely dispersed will provide 
market trends and indicate which measure to use.  The popularity of relative valuation 
comes from its simplicity and the availability of data (Bertoncel 2006).  The benefit of 
using such method is the analysis of the operations of similar companies in the industry, 
as well as the drivers of risk and value for the companies.  With this information, an 
accurate valuation can be reached relative to the competition (Evans and Bishop 2001).
Asset Valuation
The asset based valuation approach is used when a buyer is primarily interested in 
the tangible and non-tangible assets of a company.  In the asset valuation approach, all of 
the firm’s assets and liabilities are reevaluated and applied a fair market value.  Fair 
market value is defined as the price an individual is willing to pay for similarly available
alternatives.  Accounting book value is not a recommended business valuation technique.  
It is typically incorrect to value a business based on accounting values since it usually is 
not representative of current economic value (Pratt, Reilly, and Schweihs 2000).  Once 
every asset and liability has been evaluated, the sum of the liabilities can be deducted 
from the sum of the assets to provide the value of the business enterprise.
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Starting with the balance sheet of the company, every asset and liability will need 
to be restated at fair market value; this may require appraisals for the corresponding 
disciplines.  Tangible assets which have been fully depreciated may still have economic 
value if they still have remaining usefulness.  Off-balance sheet liabilities will need to be 
recorded, although this is usually less common as firms do not have contingent liabilities.  
In addition, intangible assets will need to be recorded which may or may not have been 
included in the balance sheet.  These include leasehold estates, rights, patents, and 
trademarks.  These intangible values can be valued using the income-based approach, 
estimating the income capitalization from the use, forbearance, license, or rental of the 
intangible assets (Pratt, Reilly, and Schweihs 2000).  Similarly, the market approach can 
be utilized to compare with similar intangible products sold/licensed in the primary or 
secondary markets.   The income-base and the market approach can be used to determine 
the market value for tangible and intangible assets.  Once all assets and liabilities are 
recognized and valued, it is simply a matter of subtracting the liabilities from the assets to 
realize the business value of the firm.
The advantage to using the asset based valuation approach is that it itemizes the 
business’s assets and liabilities.  Thus, this method identifies which assets are 
contributing to the economic value of the firm, and the degree to which these assets 
provide value.  In addition, this method can quantify the effect of the business decision 
pertaining to the purchase of any or all assets (Pratt, Reilly, and Schweihs 2000).  The 
primary disadvantage of the asset approach is the time and cost required to determine and 
appraise all assets (tangible and intangible) and liabilities for the entire firm.  This would 
require appraisers of different specialization, thus becoming cost prohibitive for larger 
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and complex firms.  However, such an undertaking can pinpoint the strengths and 
weaknesses of the firm, and potentially help improve the firm’s market value.  
ANALYSIS FOR INVESTORS AND STAKEHOLDERS
In the past few years, numerous mergers and acquisitions have taken place within 
the chemical industry.  These include Akzo Nobel’s purchase of ICI for ₤8 billion, Basell 
acquisition of Lyondell for $19.4 billion, and Dow Chemical’s latest attempt to acquire 
Rohm & Haas (Ovrebekk 2008).  A merger or acquisition between firms should be used 
as a strategic tool and a long-term proposition (Godfrey 2009).  Between recognizing a 
potential M&A and fully integrating into a single enterprise, numerous factors can play a 
role in determining the success or failure of the deal.  It is crucial for management to 
know what they are buying and what they are getting themselves into (Perry and Herd 
2004).  Due diligence with a clear strategic reason for the merger and an understanding of 
the economic run-up of purchases can assist investors and stakeholders from an ill 
advised acquisition.  
Reason for the Deal
M&A’s have had numerous roles in the chemical industry.  These include 
strengthening existing product line through new capabilities and extending into new 
geographic markets, and developing successful operations in advance of the competition 
(Weston, Johnson, and Siu 1999).  Before any decisions are made concerning a merger, 
business leaders need to determine the strategic rationale for the deal as it relates to the 
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corporate goals.  Often times the basis include benefits of scale, scope, and competitive 
advantages.  In 2005, the sale of Basell by BASF and Shell to Nell Acquisition for €4.4 
billion, and the purchase of GE Plastics by Saudi Basic Industries (SABIC) in 2007 for 
$11.6 billion were for the capital intensive polymers class, providing access to raw 
materials and economies of scale to become cost efficient (Jones 2007).  
Every deal should address the challenges associated with the corporate goals 
(Gadiesh, Ormiston, and Rovit 2003).  Leaders should begin by asking themselves basic 
questions relating to their business and what they hope to achieve through the acquisition.  
Management should understand the capability of its business, and its ability to 
successfully execute the merger.  Business leaders should also determine the present 
business cycle as well the timing analysis for the deal (due to possible market downturn).  
This will allow the leaders to forecast any possible changes (i.e. market and competitive 
behaviors) during the course of the merger which may impede achieving their goals 
(Jones 2007).  While the chemical industry is known for its relative long investment 
cycles and payback periods, investors have aggressively driven chemical mergers to 
higher prices, and financed and leveraged deals at aggressive levels.  This has worried 
some observers of the increased risks of default during a downward business cycle (Jones
2007).
One year after the merger between Lyondell and Basell, a group of creditors sued 
the lenders, executives, and former board of Lyondell Chemicals for driving the company 
into bankruptcy.  According to the lawsuit filed by the creditors, the merger focused on 
the million dollar payouts (to corporate executives and directors) despite signs that the 
company would go bankrupt in an economic downturn (Greenwood 2009).  Creditors 
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state that Merrill Lynch helped produce inflated projections, stating that the merged 
company could survive a downturn while carrying debt in excess of $20 billion.  The 
lawsuit states that Leonard Blavatnik, owner of Access Industries, was driven to pursue 
the deal since it would be financed entirely by debt – placing no risk on his own money 
(Greenwood 2009).  After Blavatnik failed to acquire GE Plastics and Huntsman in 2007, 
he was determined to acquire Lyondell at any price.  The lawsuit states that leading 
analysts predicted a downturn in the petrochemical industry, and the prospect of the 
merger even worried Blavatnik’s executives; Basell CEO Volker Trautz had opposed the 
deal (Greenwood 2009).  Poorly supported mergers will fail to reach projected 
performance due to management falling in love with the deal.  The numbers will be 
stretched to fit the rationale, making the projections difficult to realize (Godfrey 2009).
Leaders should announce the intention of the deal once the strategic reason is 
determined, and an analysis of the target firm is completed.  Leadership team to drive the 
merger should be formed to answer basic questions for the stakeholders including: What 
is the purpose of the deal?  Who will be driving the deal?  How will it affect the 
stakeholders?
Valuing Synergy 
One of the primary justifications for the premium paid is the synergy formed 
through the merger.  The premium for the Takeda/Millennium deal was 53% and Dow 
Chemical was willing to pay a 70% premium for the takeover of Rohm & Haas.  Paying a 
high premium can be justified if the synergies are captured, either through cost synergies 
21
or revenue synergies (Hornke 2009).  As mentioned above, revenue synergies are often 
difficult to capture, and thus calculations are based on cost synergies since they are easier 
to estimate using the information available during the deal (Early 2004).  However, if the 
synergies set forth during the negotiations cannot be captured after the merger, an 
unjustified price was paid for the deal.  The targeted cost synergy in the 
Roche/Genentech deal was $750 – 850 million and €240 – 260 million for the 
Henkel/National Starch deal.  Since these and other targets were produced prior to the 
2008 economic downturn, firms are under pressure to capture the targeted cost synergies 
since revenue synergies are unlikely (Hornke 2009).
Financing the Deal
Since the late 1990s, there has been some correlation between the Dow Jones 
index and the overall value of M&A transaction within the chemical industry for deals 
greater than $50 million, as shown in figure 2.
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Figure 2: M&A deals versus the Dow Jones Index (Jones 2007).
The overall value of chemical M&A transactions grew as the Dow Jones index 
performed positively (Jones 2007).  In response, excess liquidity in the debt market has 
prompted many financial institutions to lend money.  High liquidity has brought investors 
from the Middle East, India, and China to participate in the European chemicals M&A 
market.  Chinese companies have been interested in gaining technological benefits, 
whereas India is seeking to enter new markets.  As a result of the high liquidity, the level 
of equity required to finance a deal has decreased significantly from 40% to 25%
Chemical companies have also attracted private equity (PE) houses due to its high 
level of profitability, the ability to exit from the investment, and the cash position and 
cheap assets of the chemical firms (S.A 2007).  Basell was once purchased by an 
investment firm whose plan was likely to exit the investment once Basell had attractive 
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levels of profitability (Jones 2007).  PE firms have also increased M&A’s within the 
chemical industry, and thereby increasing the enterprise value.  In 2007, PE deals jumped 
to 9.9x EBITDA from 6.1x EBITDA in 2001; multiples stayed high due to stiff bidding 
from PE’s (Chu 2008).
The main difficulty within the chemical industry is understanding the complexity 
of the business model (Chu 2008), and the limited resources to understand the business 
model and cycle within the chemical industry (Jones 2007).  The long payback and 
investment period in the chemical industry has become financially risky for many PE 
firms.  This risk becomes even more apparent when the market cycle indicates a 
downward turn, preventing PE firms to exit the investments (S.A 2007).
Cyclicality is regarded as constant challenge within the chemical industry.  Cash 
flow require accounting for the financing cycles which affect the price an investor is 
willing to pay for the assets (KPMG 2007).  As a result, market experience and an 
overview of the cycles are required to foresee business cycles.  The latest run-up of 
chemical M&A activities and valuation is a result of excess liquidity.  Therefore, it is 
critical to determine what added value a target firm can bring to a buyer. A common 
mistake is failing to evaluate the target’s future growth rate and profitability against 
changing conditions in the economics and competitive environments.  Forecasting an 
unrealistic growth rate can have consequential effects in the target’s valuation (Perry and 
Herd 2004).  The price paid for the acquisition should be based upon achievable 
synergies and value added to the buyer in context of the changing business cycle.
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Due Diligence
Due diligence refers to the commercial analysis conducted by a potential buyer to 
gain an understanding of what is purchased from the target firm.  This process seeks to 
identify issues which may leverage the asking price for the target firm (Godfrey 2009).  
Issues including business performance, risks, legal, and compliance can reveal strengths 
and weaknesses of the firm for which the acquirer will be responsible.  From the 
cyclicality of the business to the complexity of the production sites, potential buyers face 
numerous challenges in identifying potential value and risks of the target firm (Jones 
2007).  However, proper due diligence can better inform the acquirer on what is being
purchased.
One of the challenges involved with the due diligence process is that it is often 
handled by consultants comprised of lawyers and accountants who do not have a 
technical or commercial experience in the chemical industry (Godfrey 2009).  As a result, 
an analysis is made without the consideration of critical factors affecting the chemical 
firms.  Therefore, the investigation should be performed by industry experts with proven 
track records who are able to quickly identify areas which may hurt the acquirer.
Due diligence process requires time and money which are not recoverable if the 
transaction should fail.  As a result, the process generally begins when exclusivity to the 
deal is provided, and the due diligence process begins after the lawyers and accountants 
have been appointed, causing duplicate work and poor control on the due diligence 
process (Godfrey 2009).
The due diligence process should be properly executed to avoid hidden surprises 
after the deal has been signed.  Ample time should be provided to complete the due 
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diligence process.  Sellers will attempt to arrange for a narrow timetable for the deal, 
pressuring buyers into setting high bids without proper due diligence.  Such situations 
require neutral third parties to prevent further progress of the deal until the due diligence 
is complete.  The process should rely upon publicly available data, as well as information 
collected from on-site visits and data rooms.  Once this process is complete, the buyer 
will have the necessary information to make a decision and offer for the M&A.
METHODOLOGY
The methodology of this research began by researching on the justification for 
M&A’s.  Further examination was conducted on the inherent challenges in the 
consideration of M&A as well as possible measures to avoid overpriced M&A.   
Following this study, research was done to understand the valuation techniques available 
to estimate the value of a company.  Various variations in the valuation techniques exists, 
however emphasis was placed on understanding the basis of common valuation 
techniques.  An analysis was then performed on M&A activities within the chemical 
industry by focusing on reasons for recent M&A’s and valuations of chemical firms.  Due 
diligence process was researched for investors and stakeholders interested in M&A 
within the chemical industry.  Throughout this research, there was a focus on answering 
two questions.  The first question was ‘what factors influence the decision for mergers 
and acquisitions.’  The second question was ‘what valuation techniques and practices are 
available to measure the appropriate price for an acquisition.’  Thus this research focused 
on the rationalization for M&A’s and the appropriate price for such deals.  Research for 
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this topic was found from various sources.  These included books, articles from 
magazines, internet, and previous case study. The information gathered was organized to 
present the reasons and valuation techniques for M&A’s, and factors for recent chemical 
M&A’s.
CONCLUSION
The current global competitive environment has led many companies to pursue 
M&A’s.  One of the primary motives is to capture synergy through reduction in duplicate 
work, joint efforts, and improved processes and knowledge sharing.  The difficulty exists 
in accurately estimating the monetary value added through the merger, and achieving the 
synergies set forth.  Companies also see M&A as a quick approach for growth and 
competitive advantages.  Through such measures, firms are able to quickly reach 
expanded customer base and enter into new geographic regions.  Often times M&A deals 
are reached due to management questionable reasoning.  Management should 
subjectively analyze the costs and benefits associated with any M&A deal.  Deals should 
only be pursued if the value added to the firm outweighs the associated cost.
There are numerous methods available to prevent decision-makers from an 
overpriced acquisition.  The commonly used technique is the discount cash flow which 
estimates the present value of a target firm based on future cash flow.  The market 
multiple estimates the value of a firm based on comparisons of similar firms.  Asset 
valuation simply calculates the net worth of a firm based on liquidation of assets.
The best practice for M&A deals should begin with the due diligence process in 
thoroughly understanding what the buyer is acquiring.  In addition, the deal should align 
with the corporate goals and help the firm reach these goals.  Attainable synergies should 
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be identified and captured, and the value added to the purchaser should equate to the 
synergies identified.  Any purchase price above the value added to the buyer should be 
cautioned against.  Consideration should be placed on current and future economic 
outlook as well as the business cycle.
As the competitive environment grows stiffer, an increasing level of M&A 
activities will be seen within the chemical industry from developing countries such as 
India and China.  Greater number of companies from the developing countries will seek 
M&A’s with firms in the United States and Europe.  The primary rationale will be for 
faster market growth and access to new customer base.  Firm from the developing 
countries will also have access to new technology.  With the decline in the dollar, foreign 
countries with a massive reserve in the dollar will have the finance available for an 
(overpriced) acquisition.  Although a higher premium for such acquisitions will likely be 
paid, it may be validated from the intangible synergies these foreign firms capture, 
including access to newer technology, brand awareness, and market perception.   An 
understanding of the foreign factors which can affect (the valuation of) a target firm can 
allow an investor to make an informed acquisition going forward.
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